These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical usefulness of coregistered 11C-methionine positron emission tomography/3-T magnetic resonance imaging at the follow-up of acromegaly. Rodriguez-Barcelo S; Gutierrez-Cardo A; Dominguez-Paez M; Medina-Imbroda J; Romero-Moreno L; Arraez-Sanchez M World Neurosurg; 2014; 82(3-4):468-73. PubMed ID: 24239736 [TBL] [Abstract][Full Text] [Related]
4. Clinical application of combination [ Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI. Koulouri O; Kandasamy N; Hoole AC; Gillett D; Heard S; Powlson AS; O'Donovan DG; Annamalai AK; Simpson HL; Akker SA; Aylwin SJ; Brooke A; Buch H; Levy MJ; Martin N; Morris D; Parkinson C; Tysome JR; Santarius T; Donnelly N; Buscombe J; Boros I; Smith R; Aigbirhio F; Antoun NM; Burnet NG; Cheow H; Mannion RJ; Pickard JD; Gurnell M Eur J Endocrinol; 2016 Nov; 175(5):485-498. PubMed ID: 27562400 [TBL] [Abstract][Full Text] [Related]
6. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Tang BN; Levivier M; Heureux M; Wikler D; Massager N; Devriendt D; David P; Dumarey N; Corvilain B; Goldman S Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):169-78. PubMed ID: 16228237 [TBL] [Abstract][Full Text] [Related]
7. Bakker LEH; Verstegen MJT; Manole DC; Lu H; Decramer TJM; Pelsma ICM; Kruit MC; Verbist BM; van de Ven A; Gurnell M; Ghariq I; van Furth WR; Biermasz NR; Pereira Arias-Bouda LM Clin Endocrinol (Oxf); 2024 Aug; 101(2):142-152. PubMed ID: 38818709 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography in acromegaly and other pituitary adenoma patients. Muhr C Neuroendocrinology; 2006; 83(3-4):205-10. PubMed ID: 17047384 [TBL] [Abstract][Full Text] [Related]
9. Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findings. Ishida A; Kaneko K; Minamimoto R; Hotta M; Inoshita N; Takano K; Yamada S J Neurosurg; 2023 Dec; 139(6):1671-1680. PubMed ID: 37410630 [TBL] [Abstract][Full Text] [Related]
10. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome. Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763 [TBL] [Abstract][Full Text] [Related]
11. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery. Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035 [TBL] [Abstract][Full Text] [Related]
12. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [TBL] [Abstract][Full Text] [Related]
17. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas. Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998 [TBL] [Abstract][Full Text] [Related]
18. Methyl- Niitsu H; Fukumitsu N; Tanaka K; Mizumoto M; Nakai K; Matsuda M; Ishikawa E; Hatano K; Hashimoto T; Kamizawa S; Sakurai H Ann Nucl Med; 2024 Apr; 38(4):305-314. PubMed ID: 38356008 [TBL] [Abstract][Full Text] [Related]